Heart disease Clinical Trials in Bowling Green, KY
As of June 2026, 6 paid clinical trials are recruiting for Heart disease in Bowling Green, Kentucky. Heart disease research tests new drug therapies, device-based interventions, and lifestyle programs for heart failure, atrial fibrillation, hypertension, and coronary disease — including therapies that reduce hospitalization and cardiovascular death. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
6 clinical trials for Heart disease
·Clear filters·↓ Download CSVOCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches
A Pivotal Study to Evaluate the Effectiveness of Isometric Handgrip Therapy in Elevated Blood Pressure and Hypertensive Subjects
About research studies in Bowling Green
Bowling Green has approximately 41 recruiting research studies across a wide range of therapeutic areas. Kentucky hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Bowling Green
Researchers run research studies in Bowling Green, KY at 20 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Equity Medical - Bowling Green | Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, Overweight or Obesity | 7 |
| Equity Medical, LLC | Atopic Dermatitis, Chronic Inducible Urticaria, Cold Urticaria | 6 |
| Barren River Area Development District | Diabetes Mellitus, Type 2 | 2 |
| Equity Medical | Chronic Cutaneous Lupus Erythematosus, Hidradenitis Suppurativa (HS), Subacute Cutaneous Lupus Erythematosus | 2 |
| Graves Gilbert Clinic | Cardiovascular Disease, Psoriatic Arthritis | 2 |
| Investigative | Hidradenitis Suppurativa, Hidradenitis Suppurativa (HS) | 2 |
| Atd002 52014 | Atopic Dermatitis | 1 |
| Circuit Clinical Grave Gilbert | Elevated Blood Pressure, Hypertension | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Equity Medical LLC | Chronic Spontaneous Urticaria (CSU) | 1 |
| Equity Medical LLC (Kentucky) | Hidradenitis Suppurativa (HS) | 1 |
| Galderma Investigational Site (#7129) | Chronic Pruritus of Unknown Origin | 1 |
| Greenview Surg Ctr | Lumbar Spinal Stenosis | 1 |
| Kelly Thompson Hall | Driving Impaired | 1 |
| Oruka Therapeutics Investigative Site | Plaque Psoriasis | 1 |
| Qualmedica Research | Breast Reconstruction | 1 |
| Qualmedica Research - Bowling Green | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 1 |
| Rachel Tinius | Postpartum, Pregnancy Related | 1 |
| The Medical Center | Heart Failure, Heart Failure With Preserved Ejection Fraction (HFPEF), Heart Failure With Reduced Ejection Fraction (HFrEF) | 1 |
| Wellskin Dermatology & Aesthetics | NonSegmental Vitiligo | 1 |
Active & Upcoming Studies in Bowling Green (2026)
Recruiting trials in Bowling Green grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Diabetes & metabolic (4 active studies)
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO) · Phase 4 · Eli Lilly and Company
Cardiovascular (4 active studies)
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Cancer & tumors (1 active study)
- Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma · Phase 3 · Regeneron Pharmaceuticals
Common conditions studied in Bowling Green
- Atopic Dermatitis (4 active studies). Atopic dermatitis studies test IL-13 inhibitors, JAK inhibitors, and next-generation topical therapies for moderate-to-severe eczema.
- Diabetes Mellitus, Type 2 (3 active studies). Diabetes trials evaluate new insulin formulations, GLP-1 receptor agonists, continuous glucose monitoring technologies, and disease-modifying therapies.
- Hidradenitis Suppurativa (3 active studies). Recruiting Hidradenitis Suppurativa studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Hidradenitis Suppurativa (HS) (3 active studies). Recruiting Hidradenitis Suppurativa (HS) studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Hypertension (3 active studies). Hypertension research tests new antihypertensive drug classes, renal denervation devices, and fixed-dose combinations for resistant disease.
- Cardiovascular Disease (2 active studies). Recruiting Cardiovascular Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Bowling Green
- Incyte Corporation
- AbbVie
- AstraZeneca
- Immunovant Sciences GmbH
- Sanofi
Local regulations and guidelines
Clinical trials in Kentucky are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Kentucky research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Bowling Green. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Bowling Green
Hipa.ai aggregates every recruiting study in Bowling Green from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Bowling Green?
There are approximately 41 recruiting clinical trials in Bowling Green, Kentucky listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Bowling Green pay participants?
Most recruiting trials in Bowling Green compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Bowling Green?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Bowling Green?
The most common conditions under active study in Bowling Green include Atopic Dermatitis (4), Diabetes Mellitus, Type 2 (3), Hidradenitis Suppurativa (3), Hidradenitis Suppurativa (HS) (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Bowling Green?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Bowling Green on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Bowling Green?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Bowling Green?
Recruiting research sites in Bowling Green include Equity Medical - Bowling Green, Equity Medical, LLC, Barren River Area Development District, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Bowling Green right now?
The largest active categories in Bowling Green are Diabetes & metabolic (4), Cardiovascular (4), Cancer & tumors (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.